[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6010 followers
Created: 2025-07-21 14:49:13 UTC

Cipla Invests in iCaltech to Boost Respiratory Diagnostics 🏥💡 | MCap 1,19,183.69 Cr

- Cipla acquires XX% voting rights in iCaltech for ~INR X crore.
- iCaltech is a Bangalore-based medical devices firm specializing in respiratory diagnostics.
- iCaltech’s revenue: INR XXXX cr (FY25), up from INR XXXX cr (FY24) and INR XXXX cr (FY23).
- Cipla ranks 3rd in Indian pharma and 4th in US generic inhalation products.
- iCaltech is ISO 13485 certified, focusing on regulatory-approved diagnostic devices.
- Partnership aligns with Cipla’s focus on digital, devices, and diagnostics in healthcare.
- Deal expected to close within X month.

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

![](https://pbs.twimg.com/media/GwY6DVMX0AAelKf.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947307883471016135/c:line.svg)

**Related Topics**
[indian rupee](/topic/indian-rupee)
[mcap](/topic/mcap)
[$ciplans](/topic/$ciplans)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1947307883471016135)